Platinum based Cancer Drug Market

Platinum-based antineoplastic drugs (informally called platins) are chemotherapeutic agents used to treat cancer. They are coordination complexes of platinum. These drugs are used to treat almost half of people receiving chemotherapy for cancer. In this form of chemotherapy, popular drugs include cisplatin, oxaliplatin, and carboplatin, but several have been proposed or are under development.

Platinum based Cancer Drug Market contains market size and forecasts of Platinum based Cancer Drug in global, including the following market information:

Global Platinum based Cancer Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Platinum based Cancer Drug Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Platinum based Cancer Drug companies in 2021 (%)

The global Platinum based Cancer Drug market was valued at 1586.5 million in 2021 and is projected to reach US$ 1896.7 million by 2028, at a CAGR of 2.6% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Cisplatin Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Platinum based Cancer Drug include Sanofi, Hengrui Medicine, ASK Pharma, Yi Bai Pharmaceutical, Qilu Pharmaceutical, Teva, Pfizer, Dr Reddy's Laboratories and Mylan, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Platinum based Cancer Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Platinum based Cancer Drug Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Platinum based Cancer Drug Market Segment Percentages, by Type, 2021 (%)

Cisplatin

Oxaliplatin

Carboplatin

Others

Global Platinum based Cancer Drug Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Platinum based Cancer Drug Market Segment Percentages, by Application, 2021 (%)

Colorectal Cancer

Ovarian Cancer

Lung Cancer

Others

Global Platinum based Cancer Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Platinum based Cancer Drug Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Platinum based Cancer Drug revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Platinum based Cancer Drug revenues share in global market, 2021 (%)

Key companies Platinum based Cancer Drug sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Platinum based Cancer Drug sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Sanofi

Hengrui Medicine

ASK Pharma

Yi Bai Pharmaceutical

Qilu Pharmaceutical

Teva

Pfizer

Dr Reddy's Laboratories

Mylan

Sun Pharma

Novartis

Debiopharm

Accord Healthcare

SK Chemicals